Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume 47, Issue 1, Pages 4066-4088
Publisher
Informa UK Limited
Online
2019-10-18
DOI
10.1080/21691401.2019.1677680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology
- (2019) Thomas Ming Swi Chang Artificial Cells Nanomedicine and Biotechnology
- Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo
- (2018) Shu Yao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity
- (2018) Hadi Zare-Zardini et al. Scientific Reports
- In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy
- (2018) Güliz Ak et al. Artificial Cells Nanomedicine and Biotechnology
- Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes
- (2017) Sophieke C.H.A. van der Steen et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis
- (2017) Jingxin Mo et al. Nanoscale
- Tumor-targeting templated silica nanoparticles as a dual-drug delivery system for anti-angiogenic ovarian cancer therapy
- (2017) Tianying Zheng et al. Experimental and Therapeutic Medicine
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Antitumor effects of cecropin B-LHRH’ on drug-resistant ovarian and endometrial cancer cells
- (2016) Xiaoyong Li et al. BMC CANCER
- Recent advances in polymeric micelles for anti-cancer drug delivery
- (2016) Swati Biswas et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals
- (2016) Bo Sun et al. JOURNAL OF CONTROLLED RELEASE
- Precision targeted therapy of ovarian cancer
- (2016) Justin Sapiezynski et al. JOURNAL OF CONTROLLED RELEASE
- Biocompatible Targeting Hydrogels for Breast Cancer Treatment
- (2016) R. Cassano et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells
- (2016) Hitesh Kulhari et al. MOLECULAR PHARMACEUTICS
- Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments
- (2015) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance
- (2015) Steven K. Jones et al. BIOMACROMOLECULES
- Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment
- (2015) Liqiong Cai et al. BIOMATERIALS
- Polymer-Drug Conjugates for Anticancer Drug Delivery
- (2015) Saurabh Wadhwa et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance
- (2015) Liping Wang et al. DRUG DELIVERY
- Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer
- (2015) K. Urbanska et al. Cancer Immunology Research
- Poly(styrene-alt-maleic anhydride)-Based Diblock Copolymer Micelles Exhibit Versatile Hydrophobic Drug Loading, Drug-Dependent Release, and Internalization by Multidrug Resistant Ovarian Cancer Cells
- (2014) Michael P. Baranello et al. BIOMACROMOLECULES
- Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer
- (2014) Srinivas Ganta et al. DRUG DELIVERY
- Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy
- (2014) Lingling Fan et al. GYNECOLOGIC ONCOLOGY
- Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells
- (2014) Dimple A. Modi et al. Nanoscale
- Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells
- (2013) Cristian Vilos et al. BIOMATERIALS
- Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid–poly(ethylene glycol)–chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapy
- (2013) Tony Shing Chau Li et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
- (2013) Ishaque M. Shaikh et al. JOURNAL OF CONTROLLED RELEASE
- LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer
- (2013) Natalia V. Nukolova et al. MOLECULAR PHARMACEUTICS
- Targeted Transferrin-Modified Polymeric Micelles: Enhanced Efficacy in Vitro and in Vivo in Ovarian Carcinoma
- (2013) Rupa R. Sawant et al. MOLECULAR PHARMACEUTICS
- Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy
- (2013) Sachin Yadav et al. Artificial Cells Nanomedicine and Biotechnology
- Anti-KDEL-coated nanoparticles: A promising tumor targeting approach for ovarian cancer?
- (2012) Florence Delie et al. BIOCHIMIE
- Nanocarriers for the targeted treatment of ovarian cancers
- (2012) Julie Tomasina et al. BIOMATERIALS
- The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents
- (2012) Yan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Emerging Role of Vesicular Carriers for Therapy of Visceral Leishmaniasis: Conventional versus Novel
- (2012) Navneet Kumar et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Possible Role of Epidermal Growth Factor Receptors in the Therapy of Pancreatic Cancer
- (2012) Sahil Aggarwal et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Colloidal Carriers: A Rising Tool for Therapy of Tuberculosis
- (2012) Swati Gupta et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG–PE micelles in ovarian cancer cell spheroid model
- (2012) Federico Perche et al. JOURNAL OF CONTROLLED RELEASE
- Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: Evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer
- (2012) Hyunah Cho et al. JOURNAL OF CONTROLLED RELEASE
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro
- (2012) Joseph Tai et al. PHYTOMEDICINE
- Drug Delivery Using Nanocarriers: Indian Perspective
- (2012) Swati Gupta et al. Proceedings of the National Academy of Sciences, India. Section B
- Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
- (2011) J. E. Kurtz et al. ANNALS OF ONCOLOGY
- Folate-decorated nanogels for targeted therapy of ovarian cancer
- (2011) Natalia V. Nukolova et al. BIOMATERIALS
- Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo
- (2011) Yuxing Zhang et al. CANCER LETTERS
- Antiproliferative activity of a phenolic extract from a native Chilean Amaranthaceae plant in drug-resistant ovarian cancer cell lines
- (2011) J. Brouwer-Visser et al. GYNECOLOGIC ONCOLOGY
- A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2011) Mark A. Morgan et al. GYNECOLOGIC ONCOLOGY
- A nomogram for estimating the probability of ovarian cancer
- (2011) Jason A. Lachance et al. GYNECOLOGIC ONCOLOGY
- Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: Experimental study in a murine model of ovarian cancer
- (2011) Pierre-Emmanuel Colombo et al. GYNECOLOGIC ONCOLOGY
- Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer
- (2011) Edward J. Tanner et al. GYNECOLOGIC ONCOLOGY
- Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A
- (2011) Xuan Zhang et al. GYNECOLOGIC ONCOLOGY
- Evaluation of Folate-targeted ChemoRad Nanoparticle as Intraperitoneal Chemoradiotherapy for Ovarian Cancer
- (2011) M.E. Werner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and Characterization of Doxorubicin Loaded Microparticles Against Experimental Visceral Leishmaniasis
- (2011) Sheeshpal Sharma et al. Journal of Biomedical Nanotechnology
- EGFR Targeted PLGA Nanoparticles Using Gemcitabine for Treatment of Pancreatic Cancer
- (2011) Sahil Aggarwal et al. Journal of Biomedical Nanotechnology
- Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors
- (2011) Gaurav Bajaj et al. JOURNAL OF CONTROLLED RELEASE
- Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
- (2011) Gordon J. Kirkpatrick et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer
- (2011) R. Fruscio et al. JNCI-Journal of the National Cancer Institute
- Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
- (2011) Daniele Vergara et al. Nanomedicine-Nanotechnology Biology and Medicine
- Long-Term Survival of Women With Epithelial Ovarian Cancer Detected by Ultrasonographic Screening
- (2011) John Rensselaer van Nagell et al. OBSTETRICS AND GYNECOLOGY
- Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
- (2011) Neeraj Lalwani et al. RADIOGRAPHICS
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Multifunctional polyglycerol-grafted Fe3O4@SiO2 nanoparticles for targeting ovarian cancer cells
- (2010) Liang Wang et al. BIOMATERIALS
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Current clinical use of biomarkers for epithelial ovarian cancer
- (2010) Richard G Moore et al. CURRENT OPINION IN ONCOLOGY
- Drug delivery strategies for therapy of visceral leishmaniasis
- (2010) Swati Gupta et al. Expert Opinion on Drug Delivery
- Effect of kenaf seed oil from different ways of extraction towards ovarian cancer cells
- (2010) Latifah Saiful Yazan et al. FOOD AND BIOPRODUCTS PROCESSING
- Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer
- (2010) Paul S. Kim et al. GYNECOLOGIC ONCOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro
- (2010) Michaela L. Krieger et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice
- (2010) A. Cirstoiu-Hapca et al. JOURNAL OF CONTROLLED RELEASE
- Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
- (2010) Murali M Yallapu et al. Journal of Ovarian Research
- Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
- (2009) Santosh Aryal et al. ACS Nano
- Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts
- (2009) Rutger W.H.M. Staffhorst et al. ANTI-CANCER DRUGS
- Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
- (2009) Zhongling Feng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer
- (2009) Zhenbo Zhang et al. CANCER LETTERS
- Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo
- (2009) X.-y. Zhang et al. CANCER RESEARCH
- Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin
- (2009) Jong Oh Kim et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of human ovarian cancer cell lines by Devil's club Oplopanax horridus
- (2009) Joseph Tai et al. JOURNAL OF ETHNOPHARMACOLOGY
- FePt Nanoparticles as an Fe Reservoir for Controlled Fe Release and Tumor Inhibition
- (2009) Chenjie Xu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
- (2009) Noriyuki Katsumata et al. LANCET
- Screening for Ovarian Cancer
- (2009) Daniel L. Clarke-Pearson NEW ENGLAND JOURNAL OF MEDICINE
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
- (2009) Yogeshkumar Malam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role
- (2009) C William Helm et al. Journal of Ovarian Research
- Targeting the EGF Receptor for Ovarian Cancer Therapy
- (2009) Reema Zeineldin et al. Journal of Oncology
- Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells
- (2008) Zhengyu Li et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
- (2008) H. Maeda et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Hydrogels in drug delivery: Progress and challenges
- (2008) Todd R. Hoare et al. POLYMER
- Nanoparticles for drug delivery in cancer treatment
- (2008) Barbara Haley et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis
- (2007) Bo Peng et al. GYNECOLOGIC ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started